Putting you at the centre of all decisions affecting your health
30% of the European population lives with allergies, asthma and COPD
Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Our funding partners

EFA operates with funding from membership fees, public EU funding, private unrestricted core-funding and project funding from corporate sources and donations that are disclosed every year. EFA ensures that all forms of funding are open and transparent, ensuring accountability to its sponsors and partners. EFA has a Code of Ethics and Conduct and retains a sustainable partnership with industry to ensure its integrity when receiving funding from corporate sources.

 

Our Annual Report

The Annual Report, including audited financial accounts and overall budget for the next year is approved by the Annual General Meeting of Members.

Here are the reports from 2015201420132012201120102009200820072006 and 2005.

 

2015 Annual Accounts

EFA thanks sincerily our funding partners who have made our work in 2015 possible:

Sustainable partnership with industry

 

- Operating programme sustainability

 

Air Liquide Sante International 

28.000,00

ALK Abello 

28.000,00

Astra Zeneca

28.000,00

Boehringer Ingelheim International 

28.000,00
Chiesi (donation) 15.000,00

GSK 

28.000,00

Novartis 

33.000,00

Stallergenes

28.000,00

TEVA

28.000,00

- Project programme sustainability

 
EFA Asthma Project
 
Astra Zeneca 30.000,00
GSK 30.000,00
Novartis  30.000,00
TEVA 30.000,00
EFA Capacity Building Project
 

Boehringer Ingelheim International 

30.000,00

Novartis 

30.000,00
EFA COPD Project
 
Astra Zeneca 35.000,00
Novartis  35.000,00